Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zenas Biopharma Inc shares valued at $449,100 were purchased by MOULDER LEON O JR on Dec 04 ’24. At $9.98 per share, MOULDER LEON O JR acquired 45,000 shares. The insider’s holdings grew to 241,155 shares worth approximately $2.24 million following the completion of this transaction.
Also, MOULDER LEON O JR purchased 25,000 shares, netting a total of over 269,000 in proceeds. Following the buying of shares at $10.76 each, the insider now holds 196,155 shares.
Before that, MOULDER LEON O JR had added 7,500 shares to its account. In a trade valued at $112,500, the Chief Executive Officer bought Zenas Biopharma Inc shares for $15.00 each. Upon closing the transaction, the insider’s holdings increased to 7,500 shares, worth approximately $1.57 million.
As published in their initiating research note from H.C. Wainwright on December 16, 2024, Zenas Biopharma Inc [ZBIO] has been a Buy and the price target has been revised to $30. Analysts at Rodman & Renshaw started covering the stock with ‘”a Buy”‘ outlook in a report released in early November. As of October 08, 2024, Morgan Stanley has initiated its “an Overweight” rating for ZBIO. Earlier on October 08, 2024, Jefferies initiated its rating. Their recommendation was “a Buy” for ZBIO stock.
Analyzing ZBIO Stock Performance
During the last five days, there has been a surge of approximately 13.31%. Over the course of the year, Zenas Biopharma Inc shares have jumped approximately 13.31%. Nevertheless, trading volume fell to 0.2 million shares from 0.23 million shares the previous day.
Support And Resistance Levels for Zenas Biopharma Inc (ZBIO)
According to the 24-hour chart, there is a support level at 8.94, which, if violated, would cause prices to drop to 8.60. In the upper region, resistance lies at 9.87. The next price resistance is at 10.46. RSI (Relative Strength Index) is 41.15 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.20, which suggests the price will decrease in the coming days. Percent R is at 52.85%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
